Table 2 Sensitivity of MCA (*≥11 or **≥15 U/mL cut-off values)-CA15.3 and CEA-TPA-CA15.3 panels in the early detection of 19 relapses during an intensive post-operative follow-up with tumour markers.
| Â | CE or PI of tumour markers as the initial pathological finding of relapse | ||||
|---|---|---|---|---|---|
Tumour marker association | aRelapses (total, n) | Sensitivity (%) | Tumour marker increase | Lead time (months) m + sd (range) | |
| Â | Â | Â | type | n | Â |
*MCA-CA15.3 | 13 | 68 | CE PI | 8 5 | 7.1 ± 6.8 (0–22) |
CEA-TPA-CA15.3 | 10 | 53 | CE PI | 5 5 | 3.9 ± 4.9 (0–14) |
**MCA-CA15.3 | 11 | 58 | CE PI | 8 3 | 5.9 ± 6.7 (0–18) |
CEA-TPA-CA15.3 | 14 | 74 | CE PI | 8 6 | 4.6 ± 5.9 (0–18) |